Skip to main content

For people 6+ with moderate to severe plaque psoriasis

Purple to pink gradient background

COSENTYX® (secukinumab) IS THE #1 PRESCRIBED MEDICINE OF ITS KIND

Looking for a plaque psoriasis treatment with proven experience?

Across all indications combined.

Across all indications combined. As of December 2023.

Did you know COSENTYX is currently approved to treat 8 autoimmune inflammatory conditions? In fact, more clinical trials are ongoing in several of these areas and more.

COSENTYX has been extensively studied for over 16 years in dozens of clinical trials across 8 conditions. More clinical trials are ongoing as we stay committed to studying COSENTYX for people with these conditions and more:

“I chose COSENTYX because I weighed out my options and felt like it was the right one for me. And I can tell you that clear skin can last. For me, it’s been 5 years and counting.”

cyndi

Individual results may vary. Cyndi was compensated for her time.

BETTER TOGETHER: MEET ACTUAL PATIENTS

Get to know Cyndi, Gary, LauraLee, and other actual patients living with psoriasis, psoriatic arthritis, or both.

And to hear more about COSENTYX from our patient advocates, watch the next stories in the BETTER TOGETHER series on our patient videos page.

*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.